Cargando…

An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result

The purpose of this study is to compare the treatment outcome of different radiation doses of elective neck irradiation (ENI) in nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiotherapy (IMRT). In total, 504 patients with nondisseminated NPC who underwent magnetic resona...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Tsung-Min, Fan, Kang-Hsing, Chen, Eric Yen-Chao, Lin, Chien-Yu, Kang, Chung-Jan, Huang, Shiang-Fu, Liao, Chun-Ta, Ng, Shu-Hang, Wang, Hung-Ming, Chang, Joseph Tung-Chieh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313001/
https://www.ncbi.nlm.nih.gov/pubmed/28178144
http://dx.doi.org/10.1097/MD.0000000000006036
_version_ 1782508293122424832
author Hung, Tsung-Min
Fan, Kang-Hsing
Chen, Eric Yen-Chao
Lin, Chien-Yu
Kang, Chung-Jan
Huang, Shiang-Fu
Liao, Chun-Ta
Ng, Shu-Hang
Wang, Hung-Ming
Chang, Joseph Tung-Chieh
author_facet Hung, Tsung-Min
Fan, Kang-Hsing
Chen, Eric Yen-Chao
Lin, Chien-Yu
Kang, Chung-Jan
Huang, Shiang-Fu
Liao, Chun-Ta
Ng, Shu-Hang
Wang, Hung-Ming
Chang, Joseph Tung-Chieh
author_sort Hung, Tsung-Min
collection PubMed
description The purpose of this study is to compare the treatment outcome of different radiation doses of elective neck irradiation (ENI) in nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiotherapy (IMRT). In total, 504 patients with nondisseminated NPC who underwent magnetic resonance imaging before radical IMRT between 2000 and 2008 were retrospectively reviewed. The patients were classified into 2 groups based on the ENI dose: low ENI when the ENI dose was 46 Gy (n = 446) and high ENI when the ENI doses were 50 to 60 Gy (n = 58). All the patients in both the groups received a median dose of 72 Gy to the gross tumor and involved nodes. The fraction size was 2 Gy per fraction. Matching was performed between low ENI and high ENI in a 2:1 ratio, and the matching criteria were N-stage, T-stage, treatment modality, pathology classification, sex, and age. The median follow-up for all patients was 63.5 months. In all patients, the 5-year progression-free survival (PFS), local control (LC), regional control (RC), distant metastasis-free survival (DMFS), overall survival (OS), and cancer-specific survival (CSS) for low ENI and high ENI patients were 69.0% and 63.2% (P = 0.331), 89.0% and 83.9% (P = 0.235), 90.1% and 85.2% (P = 0.246), 86.8% and 76.6% (P = 0.056), 77.5% and 80.8% (P = 0.926), and 84.4% and 82.5% (P = 0.237), respectively. In the matched-pair analysis, the 5-year PFS, LC, RC, DMFS, OS, and CSS for matched low ENI and high ENI patients were 74.1% and 63.2% (P = 0.134), 92.0% and 83.9% (P = 0.152), 90.1% and 85.2% (P = 0.356), 86.2% and 76.6% (P = 0.125), 87.0% and 80.8% (P = 0.102), and 88.6% and 82.5% (P = 0.080), respectively. In the multivariable analysis for all patients, the ENI group was not a significant factor for PFS, LC, RC, DMFS, OS, and CSS. A low ENI dose of 46 Gy in 23 fractions is feasible in NPC patients treated with IMRT, and this concept should be validated in the prospective studies.
format Online
Article
Text
id pubmed-5313001
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-53130012017-02-21 An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result Hung, Tsung-Min Fan, Kang-Hsing Chen, Eric Yen-Chao Lin, Chien-Yu Kang, Chung-Jan Huang, Shiang-Fu Liao, Chun-Ta Ng, Shu-Hang Wang, Hung-Ming Chang, Joseph Tung-Chieh Medicine (Baltimore) 3500 The purpose of this study is to compare the treatment outcome of different radiation doses of elective neck irradiation (ENI) in nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiotherapy (IMRT). In total, 504 patients with nondisseminated NPC who underwent magnetic resonance imaging before radical IMRT between 2000 and 2008 were retrospectively reviewed. The patients were classified into 2 groups based on the ENI dose: low ENI when the ENI dose was 46 Gy (n = 446) and high ENI when the ENI doses were 50 to 60 Gy (n = 58). All the patients in both the groups received a median dose of 72 Gy to the gross tumor and involved nodes. The fraction size was 2 Gy per fraction. Matching was performed between low ENI and high ENI in a 2:1 ratio, and the matching criteria were N-stage, T-stage, treatment modality, pathology classification, sex, and age. The median follow-up for all patients was 63.5 months. In all patients, the 5-year progression-free survival (PFS), local control (LC), regional control (RC), distant metastasis-free survival (DMFS), overall survival (OS), and cancer-specific survival (CSS) for low ENI and high ENI patients were 69.0% and 63.2% (P = 0.331), 89.0% and 83.9% (P = 0.235), 90.1% and 85.2% (P = 0.246), 86.8% and 76.6% (P = 0.056), 77.5% and 80.8% (P = 0.926), and 84.4% and 82.5% (P = 0.237), respectively. In the matched-pair analysis, the 5-year PFS, LC, RC, DMFS, OS, and CSS for matched low ENI and high ENI patients were 74.1% and 63.2% (P = 0.134), 92.0% and 83.9% (P = 0.152), 90.1% and 85.2% (P = 0.356), 86.2% and 76.6% (P = 0.125), 87.0% and 80.8% (P = 0.102), and 88.6% and 82.5% (P = 0.080), respectively. In the multivariable analysis for all patients, the ENI group was not a significant factor for PFS, LC, RC, DMFS, OS, and CSS. A low ENI dose of 46 Gy in 23 fractions is feasible in NPC patients treated with IMRT, and this concept should be validated in the prospective studies. Wolters Kluwer Health 2017-02-10 /pmc/articles/PMC5313001/ /pubmed/28178144 http://dx.doi.org/10.1097/MD.0000000000006036 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 3500
Hung, Tsung-Min
Fan, Kang-Hsing
Chen, Eric Yen-Chao
Lin, Chien-Yu
Kang, Chung-Jan
Huang, Shiang-Fu
Liao, Chun-Ta
Ng, Shu-Hang
Wang, Hung-Ming
Chang, Joseph Tung-Chieh
An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result
title An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result
title_full An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result
title_fullStr An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result
title_full_unstemmed An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result
title_short An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result
title_sort elective radiation dose of 46 gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a long-term follow-up result
topic 3500
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313001/
https://www.ncbi.nlm.nih.gov/pubmed/28178144
http://dx.doi.org/10.1097/MD.0000000000006036
work_keys_str_mv AT hungtsungmin anelectiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult
AT fankanghsing anelectiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult
AT chenericyenchao anelectiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult
AT linchienyu anelectiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult
AT kangchungjan anelectiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult
AT huangshiangfu anelectiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult
AT liaochunta anelectiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult
AT ngshuhang anelectiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult
AT wanghungming anelectiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult
AT changjosephtungchieh anelectiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult
AT hungtsungmin electiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult
AT fankanghsing electiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult
AT chenericyenchao electiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult
AT linchienyu electiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult
AT kangchungjan electiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult
AT huangshiangfu electiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult
AT liaochunta electiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult
AT ngshuhang electiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult
AT wanghungming electiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult
AT changjosephtungchieh electiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult